Trial intelligence / Profile preview

Rectal loperamide versus placebo in children with idiopathic fecal incontinence

NL-OMON25869Active, not recruiting

Sponsor
AMC Health
Start
Jan 2003
Modality
Small Molecules
Countries
1
01

Overview

Trial of loperamide in fecal incontinence (FI) and encopresis (2 arms), sponsored by AMC Health. Primary endpoints: Encopresis frequency and Rectal function. Started Jan 2003; status: active, not recruiting.

02

Drugs

loperamide
03

Conditions

fecal incontinence (FI)encopresis

Beyond the preview

Go deeper on NL-OMON25869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call